132 related articles for article (PubMed ID: 6510256)
1. Toxicity of anticholinesterases: interactions of pyridostigmine and physostigmine with soman.
Harris LW; Lennox WJ; Talbot BG; Anderson DR; Swanson DR
Drug Chem Toxicol; 1984; 7(5):507-26. PubMed ID: 6510256
[TBL] [Abstract][Full Text] [Related]
2. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
[TBL] [Abstract][Full Text] [Related]
3. Behavioral toxicity of anticholinesterases in primates: chronic physostigmine and soman interactions.
Blick DW; Miller SA; Brown GC; Murphy MR
Pharmacol Biochem Behav; 1993 Jul; 45(3):677-83. PubMed ID: 8332626
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure.
Solana RP; Gennings C; Carter WH; Anderson D; Lennox WJ; Carchman RA; Harris LW
Fundam Appl Toxicol; 1990 Nov; 15(4):814-9. PubMed ID: 2086320
[TBL] [Abstract][Full Text] [Related]
5. Acute behavioral toxicity of pyridostigmine or soman in primates.
Blick DW; Murphy MR; Brown GC; Yochmowitz MG; Fanton JW; Hartgraves SL
Toxicol Appl Pharmacol; 1994 Jun; 126(2):311-8. PubMed ID: 8209384
[TBL] [Abstract][Full Text] [Related]
6. Toxic interactions between repeated soman and chronic pyridostigmine in rodents.
Kerenyi SZ; Murphy MR; Hartgraves SL
Pharmacol Biochem Behav; 1990 Oct; 37(2):267-71. PubMed ID: 2080189
[TBL] [Abstract][Full Text] [Related]
7. The inhibition and protection of cholinesterase by physostigmine and pyridostigmine against Soman poisoning in vivo.
Xia DY; Wang LX; Pei SQ
Fundam Appl Toxicol; 1981; 1(2):217-21. PubMed ID: 7184786
[TBL] [Abstract][Full Text] [Related]
8. Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality.
Lennox WJ; Harris LW; Talbot BG; Anderson DR
Life Sci; 1985 Sep; 37(9):793-8. PubMed ID: 4033355
[TBL] [Abstract][Full Text] [Related]
9. A comparison of physostigmine and soman using taste aversion and nociception.
Romano JA; King JM; Penetar DM
Neurobehav Toxicol Teratol; 1985; 7(3):243-9. PubMed ID: 4033865
[TBL] [Abstract][Full Text] [Related]
10. Behavioral toxicity of anticholinesterases in primates: chronic pyridostigmine and soman interactions.
Blick DW; Kerenyi SZ; Miller S; Murphy MR; Brown GC; Hartgraves SL
Pharmacol Biochem Behav; 1991 Mar; 38(3):527-32. PubMed ID: 2068189
[TBL] [Abstract][Full Text] [Related]
11. Effects of carbamates on whole blood cholinesterase activity: chemical protection against soman.
Heyl WC; Harris LW; Stitcher DL
Drug Chem Toxicol; 1980; 3(3):319-32. PubMed ID: 7449657
[TBL] [Abstract][Full Text] [Related]
12. Effects of subchronic pyridostigmine pretreatment on the toxicity of soman.
Shiloff JD; Clement JG
Can J Physiol Pharmacol; 1986 Jul; 64(7):1047-9. PubMed ID: 3768795
[TBL] [Abstract][Full Text] [Related]
13. Effects of subacute administration of physostigmine on blood acetylcholinesterase activity, motor performance, and soman intoxication.
Harris LW; Anderson DR; Lennox WJ; Solana RP
Toxicol Appl Pharmacol; 1989 Feb; 97(2):267-71. PubMed ID: 2922758
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of physostigmine as a pretreatment for organophosphate poisoning.
Miller SA; Blick DW; Kerenyi SZ; Murphy MR
Pharmacol Biochem Behav; 1993 Feb; 44(2):343-7. PubMed ID: 8446666
[TBL] [Abstract][Full Text] [Related]
15. Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity.
Lallement G; Foquin A; Dorandeu F; Baubichon D; Carpentier P
Drug Chem Toxicol; 2001 May; 24(2):165-80. PubMed ID: 11360433
[TBL] [Abstract][Full Text] [Related]
16. Time Course, Behavioral Safety, and Protective Efficacy of Centrally Active Reversible Acetylcholinesterase Inhibitors in Cynomolgus Macaques.
Hamilton LR; Schachter SC; Myers TM
Neurochem Res; 2017 Jul; 42(7):1962-1971. PubMed ID: 27900576
[TBL] [Abstract][Full Text] [Related]
17. Protection against both lethal and behavioral effects of soman.
Harris LW; McDonough JH; Stitcher DL; Lennox WJ
Drug Chem Toxicol; 1984; 7(6):605-24. PubMed ID: 6534735
[TBL] [Abstract][Full Text] [Related]
18. Treatment of poisoning by soman.
Leadbeater L; Inns RH; Rylands JM
Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S225-31. PubMed ID: 4092890
[TBL] [Abstract][Full Text] [Related]
19. Pyridostigmine-induced decrement in skeletal muscle contracture is not augmented by soman.
Anderson RJ; Chamberlain WL
Neurotoxicology; 1988; 9(1):89-96. PubMed ID: 3393305
[TBL] [Abstract][Full Text] [Related]
20. In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species.
Herkert NM; Thiermann H; Worek F
Toxicol Lett; 2011 Sep; 206(1):41-6. PubMed ID: 21414391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
